Deep brain stimulation for obsessive-compulsive disorder: Systematic review and evidence-based guideline sponsored by the American society for stereotactic and functional neurosurgery and the congress of neurological surgeons (CNS) and endorsed by the CNS and American association of neurological surgeons

Neurosurgery

Volumn 75, Issue 4, 2014, Pages 327-333

  Hamani, Clement ^a   Pilitsis, Julie ^b   Rughani, Anand I ^c   Rosenow, Joshua M ^d   Patil, Parag G ^e   Slavin, Konstantin S ^f   Abosch, Aviva ^a   Eskandar, Emad ^g   Mitchell, Laura S ^h   Kalkanis, Steven ⁱ  

^a UNIVERSITY OF COLORADO   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c MAINE MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h Massachusetts General Hospital ^*  (United States)

ⁱ HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Deep brain stimulation; Guidelines; Neuromodulation; Obsessive compulsive disorder; Psychiatry

Indexed keywords

BRAIN DEPTH STIMULATION; CLINICAL GLOBAL IMPRESSION SCALE; DISEASE DURATION; EVIDENCE BASED PRACTICE; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; NEUROMODULATION; OBSESSIVE COMPULSIVE DISORDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBTHALAMIC NUCLEUS; SYSTEMATIC REVIEW; YALE BROWN OBSESSIVE COMPULSIVE SCALE; FEMALE; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PROCEDURES; UNITED STATES;

DEEP BRAIN STIMULATION; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; UNITED STATES;

EID: 84924029159     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000499     Document Type: Review

References (33)

1. Jenike MA. Clinical practice Obsessive-compulsive disorder. N Engl J Med. 2004; 350(3):259-265.
2. Eddy KT, Dutra L, Bradley R, Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clin Psychol Rev. 2004;24(8):1011-1030.
3. Fineberg NA, Gale TM. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2005;8(1):107-129.
4. Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessivecompulsive disorder. Lancet. 1999;354(9189):1526.
5. Abelson JL, Curtis GC, Sagher O, et al. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry. 2005;57(5):510-516.
6. Aouizerate B, Cuny E, Bardinet E, et al. Distinct striatal targets in treating obsessive-compulsive disorder and major depression. J Neurosurg. 2009;111(4): 775-779.
7. Blomstedt P, Sjöberg RL, Hansson M, Bodlund O, Hariz MI. Deep brain stimulation in the treatment of obsessive-compulsive disorder. World Neurosurg. 2013;80(6):e245-e253.
8. Burdick A, Foote KD, Goodman W, et al. Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive-compulsive disorder. Neurocase. 2010;16(4):321-330.
9. Chabardès S, Polosan M, Krack P, et al. Deep brain stimulation for obsessivecompulsive disorder: Subthalamic nucleus target. World Neurosurg. 2013;80(3-4): S31.e31-S31.e38.
10. Denys D, Mantione M, Figee M, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2010;67(10):1061-1068.
11. Franzini A, Messina G, Gambini O, et al. Deep-brain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients. Neurol Sci. 2010;31(3): 353-359.
12. Gabriëls L, Cosyns P, Nuttin B, Demeulemeester H, Gybels J. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatr Scand. 2003; 107(4):275-282.
13. Goodman WK, Foote KD, Greenberg BD, et al. Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggeredonset design. Biol Psychiatry. 2010;67(6):535-542.
14. Greenberg BD, Gabriels LA, Malone DA Jr, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: Worldwide experience. Mol Psychiatry. 2010;15(1):64-79.
15. Greenberg BD, Malone DA, Friehs GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006;31(11):2384-2393.
16. Huff W, Lenartz D, Schormann M, et al. Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: outcomes after one year. Clin Neurol Neurosurg. 2010;112(2):137-143.
17. Jiménez F, Nicolini H, Lozano AM, Piedimonte F, Salín R, Velasco F. Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders. World Neurosurg. 2013;80(3-4):S30. e17-S30.e25.
18. Jiménez F, Nicolini H, Lozano AM, et al. Preliminary study in patients with obsessive-compulsive disorder treated with electrical stimulation in the inferior thalamic peduncle. Neurosurgery. 2009;65(6 suppl):203-209; discussion 209.
19. Lipsman N, Neimat JS, Lozano AM. Deep brain stimulation for treatmentrefractory obsessive-compulsive disorder: The search for a valid target. Neurosurgery. 2007;61(1):1-11; discussion 11-13.
20. Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008;359(20):2121-2134.
21. Nuttin BJ, Gabriels L, van Kuyck K, Cosyns P. Electrical stimulation of the anterior limbs of the internal capsules in patients with severe obsessive-compulsive disorder: Anecdotal reports. Neurosurg Clin N Am. 2003;14(2):267-274.
22. Nuttin BJ, Gabriëls LA, Cosyns PR, et al. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery. 2003; 52(6):1263-1272; discussion 1272-1264.
23. Okun MS, Mann G, Foote KD, et al. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry. 2007;78(3):310-314.
24. Roh D, Chang WS, Chang JW, Kim CH. Long-term follow-up of deep brain stimulation for refractory obsessive-compulsive disorder. Psychiatry Res. 2012;200 (2-3):1067-1070.
25. Sturm V, Lenartz D, Koulousakis A, et al. The nucleus accumbens: A target for deep brain stimulation in obsessive-compulsive- And anxiety-disorders. J Chem Neuroanat. 2003;26(4):293-299.
26. Tsai HC, Chang CH, Pan JI, et al. Pilot study of deep brain stimulation in refractory obsessive-compulsive disorder ethnic Chinese patients. Psychiatry Clin Neurosci. 2012;66(4):303-312.
27. Aouizerate B, Cuny E, Martin-Guehl C, et al. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg. 2004;101(4):682-686.
28. Mallet L, Mesnage V, Houeto JL, et al. Compulsions, Parkinson's disease, and stimulation. Lancet. 2002;360(9342):1302-1304.
29. Robinson PD, Kalkanis SN, Linskey ME, Santaguida PL. Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines. J Neurooncol. 2010;96(1):11-16.
30. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
31. Tolin DF, Abramowitz JS, Diefenbach GJ. Defining response in clinical trials for obsessive-compulsive disorder: A signal detection analysis of the Yale-Brown obsessive compulsive scale. J Clin Psychiatry. 2005;66(12):1549-1557.
32. Farris SG, McLean CP, Van Meter PE, Simpson HB, Foa EB. Treatment response, symptom remission, and wellness in obsessive-compulsive disorder. J Clin Psychiatry. 2013;74(7):685-690.
33. Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin reuptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008;23(1):CD001765.